RecruitingNCT05904301
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Armenian Nationwide Registry of Systemic Autoimmune and Autoinflammatory Diseases
Sponsor
Santé Arménie French-Armenian Research Center
Enrollment
800 participants
Start Date
Jun 21, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.
Eligibility
Inclusion Criteria4
- Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases:
- Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease.
- Age: major and minor
- Patients who have been informed and provided with written informed consent to participate Or consent from legal representative
Exclusion Criteria3
- Patients refusing to participate in the registry
- Non-consent from legal representative
- Breastfeeding or pregnant patients
Interventions
OTHERUsual medical management of patients, additional blood and stool samples for biobanking
For all systemic diseases the following data will be collected: Clinical examination, Laboratory data, Current medications, Constitution of biobanking. For each disease: Pathology specific Activity score, Global subjective disease activity by patient and by physician.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05904301
Related Trials
Characterization of Diseases With Salivary Gland Involvement
NCT023278841 location
The Pathogenesis and Natural History of Sjogren's Disease
NCT014258921 location
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
NCT068415621 location
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT0710093829 locations
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations